MedElevator Войти в исследования
← Поиск публикаций

DOI 10.6004/jnccn.2023.0030

Медицинская библиотека · Journal of the National Comprehensive Cancer Network : JNCCN · 2023

Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Benson Al B, Venook Alan P, Al-Hawary Mahmoud M, Azad Nilofer, Chen Yi-Jen, Ciombor Kristen K, Cohen Stacey, Cooper Harry S, Deming Dustin, Garrido-Laguna Ignacio, Grem Jean L, Hecht J Randolph, Hoffe Sarah, Hubbard Joleen, Hunt Steven, Hussan Hisham, Jeck William, Johung Kimberly L, Joseph Nora, Kirilcuk Natalie, Krishnamurthi Smitha, Maratt Jennifer, Messersmith Wells A, Meyerhardt Jeffrey, Miller Eric D, Mulcahy Mary F, Nurkin Steven, Overman Michael J, Parikh Aparna, Patel Hitendra, Pedersen Katrina, Saltz Leonard, Schneider Charles, Shibata David, Skibber John M, Sofocleous Constantinos T, Stotsky-Himelfarb Eden, Tavakkoli Anna, Willett Christopher G, Williams Grant, Algieri Frankie, Gurski Lisa, Stehman Katie

СтатьяКлинические рекомендацииПеревод пока не подготовлен

Аннотация

This discussion summarizes the NCCN Clinical Practice Guidelines for managing squamous cell anal carcinoma, which represents the most common histologic form of the disease. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is necessary. Primary treatment of perianal cancer and anal canal cancer are similar and include chemoradiation in most cases. Follow-up clinical evaluations are recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. Biopsy-proven evidence of locally recurrent or persistent disease after primary treatment may require surgical treatment. Systemic therapy is generally recommended for extrapelvic metastatic disease. Recent updates to the NCCN Guidelines for Anal Carcinoma include staging classification updates based on the 9th edition of the AJCC Staging System and updates to the systemic therapy recommendations based on new data that better define optimal treatment of patients with metastatic anal carcinoma.

Для цитирования: Benson Al B, Venook Alan P, Al-Hawary Mahmoud M, Azad Nilofer, Chen Yi-Jen, Ciombor Kristen K, Cohen Stacey, Cooper Harry S, Deming Dustin, Garrido-Laguna Ignacio, Grem Jean L, Hecht J Randolph, Hoffe Sarah, Hubbard Joleen, Hunt Steven, Hussan Hisham, Jeck William, Johung Kimberly L, Joseph Nora, Kirilcuk Natalie, Krishnamurthi Smitha, Maratt Jennifer, Messersmith Wells A, Meyerhardt Jeffrey, Miller Eric D, Mulcahy Mary F, Nurkin Steven, Overman Michael J, Parikh Aparna, Patel Hitendra, Pedersen Katrina, Saltz Leonard, Schneider Charles, Shibata David, Skibber John M, Sofocleous Constantinos T, Stotsky-Himelfarb Eden, Tavakkoli Anna, Willett Christopher G, Williams Grant, Algieri Frankie, Gurski Lisa, Stehman Katie. Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 2023. DOI: 10.6004/jnccn.2023.0030.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.